Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCALL.L Regulatory News (CALL)

  • There is currently no data for CALL

Test Results & Update

18 Oct 2011 07:00

RNS Number : 3265Q
Zenergy Power PLC
18 October 2011
 



 

 

Zenergy Power PLC

("Zenergy" or "the Group")

 

Non-superconducting Magnetic FaultCurrent Limiter (MFCL) test results 

& update

 

Further to the announcement of 15 September 2011 regarding corporate restructuring and the new design non-superconducting Magnetic Fault Current Limiter ("MFCL"), Zenergy is providing a further progress update.

 

As stated previously, the Group is now focused on the MFCL market and, in particular, on non-superconducting MFCLs. Testing of key concepts have validated the non-superconducting technologies, and a half-scale prototype has been built and tested successfully. Work has already commenced on a full-scale demonstration MFCL.

 

Following this successful half-scale test, Zenergy will immediately seek to secure sales orders and commence commercial production of non-superconducting MFCLs in voltage classes; ranging from 4kv to 154kv.

 

The production and testing of an 11kv superconducting MFCL unit, (whose sale was originally announced last year), has now been completed. Fulfilment of this contract will result in Zenergy receiving £500,000 of cash net of costs.

 

The German subsidiary, Zenergy Power GmbH, has now entered into administration and is not expected to have any further material financial impact on the Group.

 

It can also be confirmed that overall operating costs are now running at approximately £4m per annum - down from £12m per annum previously. With nearly £6m in current cash balances, plus the additional £500,000 expected from the above 11kv MFCL, the Group has sufficient working capital for at least 18 months (even assuming no sales revenues).

 

Commenting, Executive Chairman, Simon Cleaver, said:

"We are delighted by the non-superconducting MFCL test results. While it's always possible that we could still encounter issues when scaling up or manufacturing the new MFCLs, these tests prove that the design and technology works and we are now in discussions with potential customers and manufacturing partners.

"The non-superconducting MFCLs are attractive because they use technology that electrical network operators are familiar with, are significantly less expensive to build, smaller and quicker to manufacture and should require much lower maintenance than the superconducting version.

"The restructuring of the Group to focus on our MFCL operations was both challenging and painful, but Zenergy is now leaner and more focused and, as a result, I believe that we are on a far sounder financial footing. We still have a great deal of work to do to bring these products to market, but independent research reports confirm that we are potentially addressing a very large MFCL marketplace. The Board will of course continue to closely monitor this progress and the strategic direction of the Group."

Ends

 

For further information please contact:

 

Simon Cleaver Zenergy Power plc +44 1344 667 347

Adam Pollock/Katherine Roe Panmure Gordon +44 207 459 3600

 

David Bick/Mark Longson Square1 Consulting +44 207 929 5599

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGAWUUPGGAM
Date   Source Headline
20th Apr 20184:20 pmRNSHoldings in Company
21st Mar 20187:00 amRNSCloudCall to present at Mello conference
20th Mar 20187:00 amRNSFinal Results
8th Mar 20187:00 amRNSCloudCall to present at London Investor Forum
7th Mar 20187:00 amRNSNotice of Results and Investor Webcast
29th Jan 20183:44 pmRNSHoldings in Company
26th Jan 20187:00 amRNSNotice of Share Option Exercise & Issue of Equity
18th Jan 20187:00 amRNSTrading Update
13th Dec 20177:00 amRNSHoldings in Company
12th Dec 20175:05 pmRNSHoldings in Company
12th Dec 20175:05 pmRNSHoldings in Company
30th Nov 20175:46 pmRNSHolding(s) in Company
29th Nov 20172:12 pmRNSFurther re. Placing
23rd Nov 20177:00 amRNSLaunch of updated Bullhorn Integration
15th Nov 20171:45 pmRNSNotice of Share Option Exercise & Issue of Equity
7th Nov 201711:05 amRNSResult of General Meeting
23rd Oct 20174:33 pmRNSHolding(s) in Company
23rd Oct 20177:00 amRNSHoldings in Company
18th Oct 20173:30 pmRNSNotice of Share Option Exercise & Issue of Equity
17th Oct 20174:20 pmRNSPosting of Circular
17th Oct 20177:00 amRNSProposed placing to raise £5.7million
12th Oct 20173:30 pmRNSNotice of Share Option Exercise & Issue of Equity
22nd Sep 201712:05 pmRNSHolding(s) in Company
20th Sep 201710:15 amRNSHolding(s) in Company
15th Sep 201712:45 pmRNSDirector/PDMR Shareholding
14th Sep 20174:10 pmRNSHolding(s) in Company
12th Sep 20178:40 amRNSHoldings in Company
11th Sep 20171:00 pmRNSDirector/PDMR Shareholding
11th Sep 20177:00 amRNSAppointment of Joint Corporate Broker
11th Sep 20177:00 amRNSInterim Results
5th Sep 20172:30 pmRNSIssue of Equity
5th Sep 20177:00 amRNSNotice of investor webcast
3rd Aug 201712:20 pmRNSNotice of Share Option Exercise
27th Jul 20177:00 amRNSNotice of Half-Year Results
12th Jul 20172:30 pmRNSDirector/PDMR Shareholding
12th Jul 20177:00 amRNSTrading Update
22nd May 20173:23 pmRNSDirector/PDMR Shareholding
22nd May 20171:15 pmRNSDirector/PDMR Shareholding
22nd May 201712:00 pmRNSResult of AGM and Board Appointment
27th Apr 20177:00 amRNSPosting of Annual Report and Notice of AGM
11th Apr 20177:00 amRNSLaunch of new mobile app
29th Mar 20172:00 pmRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
17th Mar 20177:00 amRNSNotice of investor presentation webcast
16th Mar 201710:30 amRNSHolding in Company
17th Feb 20177:00 amRNSNotice of Results
13th Feb 20177:00 amRNSUpdate on Bullhorn strategic partnership
1st Feb 20177:00 amRNSHoldings in Company
31st Jan 20177:00 amRNSHoldings in Company
10th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.